Gene transfer into vascular cells
- PMID: 2016477
- DOI: 10.1016/0735-1097(91)90957-b
Gene transfer into vascular cells
Abstract
The goal of gene therapy is to introduce foreign deoxyribonucleic acid (DNA) into somatic cells to correct or prevent disorders caused by the malfunction of genes within a diseased individual. Overexpression of recombinant genes at specific sites within the vasculature can provide insights into vascular biology and potential treatments for various cardiovascular disorders such as restenosis. Methods for the introduction of foreign DNA into endothelial and vascular smooth muscle cells have been developed recently. These include the genetic modification of endothelium in vitro and implantation in vivo on arterial segments, direct infection of the arterial wall in vivo with a replication-defective retroviral vector expressing a recombinant gene and direct transfer of genes into vascular cells in vivo with use of liposomes. Although still in its formative stages, gene transfer into the vasculature holds promise as a potential treatment for vascular diseases, including atherosclerosis and restenosis. This approach may also provide insight into the role of specific gene products in the development of pathologic lesions.
Similar articles
-
Gene transfer and cardiovascular disease.Trends Cardiovasc Med. 1991 Jan-Feb;1(1):12-7. doi: 10.1016/1050-1738(91)90053-H. Trends Cardiovasc Med. 1991. PMID: 21239340
-
Retroviral vector-mediated gene transfer into endothelial cells.Mol Biol Med. 1991 Apr;8(2):257-66. Mol Biol Med. 1991. PMID: 1806767 Review.
-
Development and use of gene transfer for treatment of cardiovascular disease.J Card Surg. 2002 Nov-Dec;17(6):543-8. doi: 10.1046/j.1540-8191.2002.01011.x. J Card Surg. 2002. PMID: 12643466 Review.
-
Arterial gene transfer to rabbit endothelial and smooth muscle cells using percutaneous delivery of an adenoviral vector.Circulation. 1994 Oct;90(4):1648-56. doi: 10.1161/01.cir.90.4.1648. Circulation. 1994. PMID: 7923648
-
Efficient transduction and seeding of human endothelial cells onto metallic stents using bicistronic pseudo-typed retroviral vectors encoding vascular endothelial growth factor.Cardiovasc Revasc Med. 2006 Jul-Sep;7(3):173-8. doi: 10.1016/j.carrev.2005.12.007. Cardiovasc Revasc Med. 2006. PMID: 16945825
Cited by
-
Cell physiology as a variable in gene transfer to endothelium.Curr Atheroscler Rep. 2003 May;5(3):171-7. doi: 10.1007/s11883-003-0020-3. Curr Atheroscler Rep. 2003. PMID: 12667428 Review.
-
A shift from cell cultures to creatures: in vivo imaging of small animals in experimental regenerative medicine.Mol Ther. 2011 Nov;19(11):1933-41. doi: 10.1038/mt.2011.194. Epub 2011 Sep 27. Mol Ther. 2011. PMID: 21952170 Free PMC article. Review.
-
Vascular Applications of Human Gene Therapy.J Thromb Thrombolysis. 1995;1(3):299-302. doi: 10.1007/BF01060740. J Thromb Thrombolysis. 1995. PMID: 10608008
-
Electroporation markedly improves Sleeping Beauty transposon-induced tumorigenesis in mice.Cancer Gene Ther. 2014 Aug;21(8):333-9. doi: 10.1038/cgt.2014.33. Epub 2014 Jul 4. Cancer Gene Ther. 2014. PMID: 24992966
-
Transfection efficiency and cytotoxicity of nonviral gene transfer reagents in human smooth muscle and endothelial cells.Pharm Res. 2004 Jun;21(6):1009-17. doi: 10.1023/b:pham.0000029291.62615.ec. Pharm Res. 2004. PMID: 15212167
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources